Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
This is a 28.6% decrease from the number of companies inspected in the previous quarter, when seven companies received seven inspections.
Most of the companies inspected at the time were involved in the Biologics sector. Both the Drugs and Food and Cosmetics sectors sectors tied for second most common type.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| American Red Cross | Biologics | 03/18/2024 | No Action Indicated (NAI) |
| OpAns, LLC | Drugs | 01/24/2024 | No Action Indicated (NAI) |
| Signature Flight Support [RDU] | Food and Cosmetics | 02/27/2024 | No Action Indicated (NAI) |
| UNC Healthcare/Fertility | Biologics | 03/19/2024 | No Action Indicated (NAI) |
| Veterans Administration Medical Center Laboratory Service | Biologics | 03/20/2024 | No Action Indicated (NAI) |
Alerts Sign-up